Apidel’s pipeline of internally funded and developed products make the most of the company’s drug delivery expertise and represent new indications or substantial improvements using already-approved active pharmaceutical ingredients.  Products in Apidel’s pipeline are available for licensing.

Field

Product

Indication

Formulation development

Pre-clinical

Clinical


Gastroenterology

Cyclosporine-ApidSOL™

Ulcerative colitis


Ophthalmology

Apid473-ApidSOL™

Multiple indications


Dermatology

Tacrolimus-ApidSOL™

Psoriasis


Apid473-ApidSOL™

Wound healing


Oncology

Triptorelin-ApidCOR™

Prostate cancer


Topical Wnt inhibitor-ApidSOL™

Cutaneous cancers


Otology

Corticosteroid-ApidCOR™

Drug induced hearing loss

Formulation development Pre-clinical Clinical

Gastroenterology

Ophthalmology

Dermatology

Oncology

Otology